Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TapImmune Inc (NASDAQ:TPIV)

4.40
Delayed Data
As of Dec 09
 -0.02 / -0.45%
Today’s Change
3.90
Today|||52-Week Range
11.35
-38.89%
Year-to-Date
No recent news for TapImmune Inc.

Today’s Trading

Previous close4.42
Today’s open4.36
Day’s range4.30 - 4.95
Volume47,712
Average volume (3 months)19,457
Market cap$37.0M
Dividend yield--
Data as of 3:59pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+61.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio6.2
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RNNRexahn Pharmaceutica...+0.00+0.81%
DMPIDelMar Pharmaceutica...-0.19-5.08%
RPRXRepros Therapeutics ...-0.03-1.95%
PRPHProPhase Labs Inc+0.03+1.49%
Data as of 4:02pm ET, 12/09/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$34.1M
Net profit margin--

Profile

Sector
Consumer Services
Industry
Other Consumer Services
Chairman, CEO, Secretary &
CAO
Glynn Wilson
President, Chief Operating Officer &
Director
John N. Bonfiglio
Corporate headquarters
Jacksonville, Florida

Forecasts


Search for Jobs